Target intelligence / Profile preview

Ras–Raf Interaction (None)

Target: None
Molecular classification: Protein-protein interaction, Signaling complex

Overview

The Ras–Raf interaction is a critical molecular event in the MAPK/ERK signaling pathway, regulating essential cellular processes. It involves direct binding between activated (GTP-bound) Ras proteins and Raf kinases (A-Raf, B-Raf, C-Raf/Raf-1). This interaction recruits Raf to the plasma membrane, relieving autoinhibition and allowing activation of the MAPK/ERK cascade. Aberrant activation, often due to mutations in RAS or RAF, is implicated in many cancers, making this interaction a therapeutic target.

Mechanism of action

Disruption of Ras-Raf protein-protein interaction

Biological functions

Signal transductionCell proliferationCell differentiationCell survival

Disease associations

Cancer

Safety considerations

SpecificityOff-target effects

Beyond the preview

Go deeper on Ras–Raf Interaction (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ras–Raf Interaction (None).

Explore the full profile